Inhibitory effects of gallium chloride and tris (8-quinolinolato) gallium III on A549 human malignant cell line

Anticancer Research

Volumn 20, Issue 2 A, 2000, Pages 955-958

  Collery, Philippe ^a   Lechenault, Fraņoise ^a   Cazabat, Annie ^a   Juvin, Edgard ^a   Khassanova, Lylia ^b   Evangelou, Angelos ^c   Keppler, Bernhard ^d  

^a HÔPITAL MAISON BLANCHE   (France)

^b Birsk Branch of Federal State Budgetary Educational Establishment of Higher Education Bashkir State University   (Russian Federation)

^c UNIVERSITY OF IOANNINA   (Greece)

^d UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cancer; Cell growth; Gallium; Metal based anticancer drug

Indexed keywords

8 QUINOLINOL DERIVATIVE; GALLIUM CHLORIDE; GALLIUM NITRATE; PYRIDOXAL ISONICOTINOYLHYDRAZONE; TRI (8 QUINOLINOLATO) GALLIUM; UNCLASSIFIED DRUG;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; PRIORITY JOURNAL;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL SURVIVAL; GALLIUM; HUMANS; KINETICS; LUNG NEOPLASMS; ORGANOMETALLIC COMPOUNDS; OXYQUINOLINE; TUMOR CELLS, CULTURED;

EID: 0034010314     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Collery Ph: Gallium compounds in cancer therapy. In: Metal compounds in cancer therapy. Ed. Simon P. Fricker. Chapman & Hall, London 1994, chapter 8, pp. 180-197.
2. Collery Ph, Millart H, Kleisbauer JP, Paillotin D, Robinet G, Durand A, Claeyssens S, Legendre JM, Leroy A, Rousseau A, Pechery C and Kochman S: Dose optimization of gallium chloride, orally administered, in combination with platinum compounds. Anticancer Res 14: 2299-2306, 1994.
3. Collery P, Millart H, Pechery C, Kratz F and Keppler B: New gallium complexes for a cisplatin combination therapy. In: Metal Ions in Biology and Medicine. Eds. J. Anastassopoulou, P. Collery, J.C. Etienne, Th. Theophanides. John Libbey Eurotext 1992, vol. 2, pp. 173-175
4. Danielpour D, Kim KY, Winokur TS and Sporn MB: Differential regulation of the expression of transforming growth factor-β 1 and 2 by retinoic acid, epidermal growth factor, and dexamethasone in NRK-49F and A549 cells. J Cell Phys 148: 235-244, 1991.
5. Kang YH, Kedar VP and Maheshwari RK: Thrombin stimulation of synthesis and secretion of fibronectin by human A549 epithelial cells and mouse LB fibroblasts. J Histochem Cytochem 39: 413-423, 1991.
6. Lieber M, Smith B, Szakal A, Nelson-Rees W and Todaro G: A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 17: 62-70, 1976.
7. Knorr GM and Chitambar CR: Gallium-pyridoxal isonicotinoyl hydrazone (Ga-PIH), a novel cytotoxic gallium complex. A comparative study with gallium nitrate. Anticancer Res 18: 1733-1738, 1998.
8. Katsir O and Malik Z: Toxic effects of gallium nitrate on Friend erytroleukemia cells. Cancer J 10: 43-48, 1997.
9. Chitambar CR, Matthaeus WG, Antholine WE, Graff K and O'Brien WJ: Inhibition of leukemic HL 60 cell growth by transferrin-gallium: effects on ribonucleotide reductase and demonstration of drug synergy with hydroxyurea. Blood 72: 1930-1936, 1988.
10. 3 inhibition of growth in human-derived small cell lung cancer cells. J Cell Biochem Suppl 24: 276-87, 1996.
11. Luttropp CA, Jackson JA, Jones BJ, Sohn MH, Lynch RE and Morton KA: Uptake of gallium-67 in transfected cells and tumors absent or enriched in the transferrin receptor. J Nucl Med 39: 1405-11, 1998.
12. Haq RU, Wereley JP and Chitambar CR: Induction of apoptosis by iron deprivation in human leukemic CCRF-CEM cells. Exp. Hemat. 23: 428-432, 1995.
13. Perchellet EM, Ladesich JB, Collery P and Perchellet JP: Microtubule-disrupting effects of gallium chloride in vitro. Anticancer Drugs 10: 477-488, 1999.
14. Ogihara-Umeda I and Kojima S: Cholesterol enhances the delivery of liposome-encapsulated gallium-67 to tumors. Eur J Nucl Med 15: 612-617, 1989.
15. Ho DH, Abrams M, Giandominico C, Bradley F, Frost D and Bekersky I: Bioavailability studies of tedradentate Schiff-base gallium complexes. Metal ions in biology and medicine. Eds. Collery P., Corbella J, Domingo JL., Etienne JC., Llobet JM. John Libbey Eurotext, Paris, 1996, 4: 369-371.
16. Collery P, Domingo JL and Keppler BK: Preclinical toxicology and tissue gallium distribution of a novel antitumour gallium compound: tris (8-quinolinolato) gallium (III). Anticancer Res 16: 687-691, 1996.
17. Thiel M, Schilling T, Gey DC, Ziegler R, Collery P, Keppler BK: Tris(8-quinolinolato)Gallium(III), a novel antitumor active gallium compound. Accepted for publication in "Contributions to Oncology" by Karger Verlag.
18. Collery P, Lechenault F, Juvin E, Khassanova L, Vernet G, Cazabat A and Lehargy F: Synergistic effects between gallium chloride and vinorelbine on U937 malignant cell lines. In: Metal Ions in Biology and Medicine. Eds. P. Collery, P. Brätter, V. Negretti de Brätter, L, Khassanova, J.C. Etienne, John Libbey Eurotext, Paris 5: 588-593, 1998.
19. Hata Y, Sandler A, Loehrer PJ, Sledge GW and Weber G: Synergism of taxol and gallium nitrate in human breast carcinoma cells: schedule dependency. Oncology Res 6: 19-24, 1994.
20. Myette MS, Elford HL and Chitambar CR: Interaction of gallium nitrate with other inhibitors of ribonucleotide reductase: effects on the proliferation on human leukemic cells. Cancer letters 129: 199-204, 1998.